Benaroya Research Institute's third annual immunology symposium, New Horizons in Immunity and Disease, took place on Tuesday, May 5, 2026. Due to strong interest and enthusiastic support from the immunology community, we relocated this year’s event to Bell Harbor International Conference Center in Seattle, a larger venue that better accommodated our growing audience.
Once again, we brought together leading voices from the local and national immunology research community for a day of collaboration, discovery, discussion and connection. Building on two years of full houses, dynamic presentations, and meaningful dialogue, this year’s symposium continued that momentum.
Please contact BRI's marketing and communications team via email with any questions.
We look forward to next year's event!
BRI Immunology Symposium Speakers
The program featured two standout keynote speakers, Jay Shendure, MD, PhD, and Phil Greenberg, MD, alongside a strong lineup of nationally and locally recognized researchers from institutions including BRI, the University of Washington, and the Allen Institute for Immunology.
BRI Thanks Our Generous Sponsors
Thank you to our partners, supporters and collaborators.
News
Carmen Mikacenic, MD, ATSF Awarded Mid-Career Award
Read More ➡
Recognizing BRI Researchers, Sheenam Verma and Sarah Kobernat, for Recent Fellowship Awards
Read More
Seattle Children’s Research Institute, Benaroya Research Institute at Virginia Mason Franciscan Health, and GentiBio Highlight Long Standing Scientific Collaboration Advancing GNTI 122 Into the Clinic
Read More
Featured Publications
Atlas of HIV cis-regulatory elements reveals extensive transcriptional variation across clades, isolates, and within individuals
bioRxiv
DYRK1A and Parkinson's disease, facts and hypotheses
Neurobiol Dis
A fast way to lose antibodies
Immunity
Defects in CD8+ T cell suppression by Foxp3-ΔE2 expressing regulatory T cells
bioRxiv
Association of epigenetic trajectory with development of clinical rheumatoid arthritis in anti-citrullinated protein antibody positive individuals: Targeting Immune Responses for Prevention of Rheumatoid Arthritis (TIP-RA)
Arthritis Rheumatol
